The relationship between the IGF-I system and its binding proteins and microvascular reactivity in Type 1 diabetes mellitus

Physiological Research

Volumn 51, Issue 4, 2002, Pages 379-385

  Krsek M ^a   Prazny M ^a   Skrha J ^a   Justova V ^a   Lacinova Z ^a   Haas, T ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

IDDM; IGF I; IGFBP 1; Laser Doppler flowmetry; Microangiopathy

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC MICROANGIOPATHY; FEMALE; HUMAN; HYPEREMIA; INSULIN DEPENDENT DIABETES MELLITUS; LASER DOPPLER FLOWMETRY; MALE; PATHOGENESIS; PROTEIN BINDING; PROTEIN FUNCTION;

BLOOD CIRCULATION; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; MIDDLE AGED; REFERENCE VALUES;

EID: 0036408754     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Barrett-Connor E, Wingard DL: Sex differential in ischemic heart disease mortality in diabetics: A prospective population-based study. Am J Epidemiol 118: 489-496, 1983.
2. Baserga R, Rubin R: Cell cycle and growth control. Crit Rev Eukaryot Gene Expr 3: 47-61, 1993.
3. Chen Y, Capron L, Magnusson JO, Wallby LA, Arnquist HJ: Insulin-like growth factor-1 stimulates vascular smooth muscle cell proliferation in rat aorta in vivo. Growth Horm IGF Res 8: 299-303, 1998.
4. Cusi K, De Fronzo RA: Treatment of NIDDM, IDDM and other insulin-resistant states with IGF-I. Diabetes Rev 3: 206-236, 1995.
5. Feldmann B, Jehle PM, Mohan S, Lang GE, Lang GK, Brueckel J, Boehm BO: Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins. Growth Horm IGF Res 10: 53-59, 2000.
6. Froesch ER, Burgi H, Ramseier ER, Bally P, Labhart A: Antibody suppressible and non-suppressible insulin-like activities in human serum and their physiological significance. An insulin assay with adipose tissue of increased precision and specificity. J Clin Invest 42: 1816-1834, 1963.
7. Gibson JM, Westwood M, Young RJ, White A: Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM). J Clin Endocrinol Metab 81: 860-863, 1996.
8. Janssen JAMJL, Lamberts SWJ: Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy. Clin Endocrinol 52: 1-9, 2000.
9. Janssen JAMJL, Jacobs ML, Derkx FHM, Weber AL, Van Der Lely AJ, Lamberts SWJ: Free and total insulin-like growth factor I (IGF I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82: 2809-2815, 1997.
10. Janssen JA, Stolk RP, Pols HA, Grobbee DE, Lamberts SWJ: Serum total IGF-I, free-IGF-I, and IGFBP-1 levels in an elderly population: Relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol 18: 277-282, 1998.
11. Lehmann ED, Riley WA, Clarkson P, Gosling RG: Non-invasive assessment of cardiovascular disease in diabetes mellitus. Lancet 350 (Suppl I): 14-18, 1997.
12. Merimee T: The interface between diabetic retinopathy, diabetes management, and insulin-like growth factors. J Clin Endocrinol Metab 82: 2806-2808, 1997.
13. Murphy LJ, Seneviratne C, Moreira P, Reid R: Enhanced expression of insulin-like growth factor binding protein-I in the fasted rat: The effects of insulin and growth hormone administration. Endocrinology 128: 689-696, 1991.
14. Rajkumar K, Krsek M, Dheen ST, Murphy LJ: Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice. J Clin Invest 98: 1818-1825, 1996.
15. Rendell M, Bergman T, O'donnell G, Drobny E, Borgos J, Bonner RF: Microvascular blood flow, volume, and velocity measured by laser-Doppler techniques in IDDM. Diabetes 38: 819-824, 1989.
16. Simpson HL, Umpleby AM, Russel-Jones DL: Insulin-like growth factor-I and diabetes. A review. Growth Horm IGF Res 8: 83-95, 1998.
17. Škrha J, Prázný M, Haas TV, Kvasnička J, Kalvodová B: Comparison of laser-Doppler flowmetry with biochemical indicators of endothelial dysfunction related to early microangiopathy in Type 1 diabetic patients. J Diabetes Complications 15: 234-240, 2001.
18. Snyder DK, Clemmons DR: Insulin-dependent regulation of insulin-like growth factor-binding protein-1. J Clin Endocrinol Metab 71: 1632-1636, 1990.